Dementia, a growing public health concern affecting millions worldwide, is characterized by progressive cognitive and functional decline. Alzheimer's disease (AD) is the most prevalent form of dementia, necessitating the exploration of new therapeutic strategies. Impaired brain energy metabolism is a notable feature of AD, leading researchers to investigate ketogenic diets as a potential intervention. This article examines the existing research on the effects of ketogenic diets on cognition, daily function, and quality of life in individuals with AD, as well as its impact on those at risk of developing AD.
Understanding Ketogenic Diets and Their Potential Benefits for Brain Health
Ketogenic diets are high-fat, low-carbohydrate diets that shift the body's metabolism from using glucose to burning fat and producing ketones for energy. Neurons can utilize ketones, produced by the liver from fats, as an alternative energy source. This metabolic shift induces a state of "physiological ketosis," where the primary blood ketone, beta-hydroxybutyrate, increases and contributes more significantly to brain energy metabolism. Ketones produce more energy per unit oxygen compared to glucose, potentially compensating for brain insulin resistance and deficient glucose metabolism observed in AD. Furthermore, ketogenic diets can upregulate mitochondrial biogenesis and induce the expression of genes associated with energy production, potentially increasing neuron energy production.
Clinical Trials Evaluating Ketogenic Diets in Alzheimer's Disease
Several clinical trials have explored the symptomatic effects of ketogenic diets in AD patients. A single-arm study involving 15 AD patients who followed a 12-week ketogenic diet showed improved cognitive scores among the 11 who completed the study. However, the absence of a control group limited the ability to rule out other contributing factors. Another randomized controlled trial provided preliminary data on the impact of a 12-week Modified Atkins diet versus a recommended diet in 14 patients with mild cognitive impairment or AD. While the most adherent patients experienced improved memory scores, overall adherence was only fair, and function did not improve.
A Randomized Crossover Trial: Ketogenic Diet Improves Daily Function and Quality of Life
To further investigate the potential benefits of ketogenic diets in AD, researchers conducted a randomized crossover trial involving 26 patients with clinically confirmed diagnoses of AD. The trial compared a 12-week modified ketogenic diet to a usual diet supplemented with low-fat healthy-eating guidelines. The study found that patients on the ketogenic diet achieved sustained physiological ketosis and demonstrated significant improvements in daily function and quality of life compared to the usual diet. While the Addenbrookes Cognitive Examination - III (ACE-III) scores also increased, the improvement was not statistically significant. The study also reported mostly favorable changes in cardiovascular risk factors and mild adverse effects.
Key Findings and Implications
The randomized crossover trial provided evidence that a 12-week modified ketogenic diet is well-tolerated and can lead to improvements in daily function and quality of life for AD patients. These findings are particularly relevant as these factors are of great importance to individuals living with dementia.
Read also: Easy Low-Carb Cheese Crackers
Investigating the Mechanisms of Action: How Ketogenic Diets May Impact Alzheimer's Disease
Beta-Hydroxybutyrate (BHB) and Synaptic Function
A study on mice demonstrated that a ketogenic diet significantly delays the early stages of Alzheimer's-related memory loss. The study identified beta-hydroxybutyrate (BHB) as a key molecule in preventing early memory decline, with levels increasing almost seven-fold on the ketogenic diet. Researchers observed that BHB improved the function of synapses, the structures that connect nerve cells in the brain, leading to improved memory in mild cognitive impairment.
Impact on Synaptic Plasticity in an Alzheimer's Disease Mouse Model
Research using the APP/PS1 mouse model of AD explored the impact of a ketogenic diet on synaptic plasticity. The study found that a 7-month ketogenic diet rescued deficient long-term potentiation (LTP), a neurophysiological measurement related to synapse-based learning and memory. RNA sequencing analysis revealed that the ketogenic diet altered synaptic plasticity, with significant induction of pathways related to synaptic long-term depression, CREB signaling in neurons, synaptic long-term potentiation, GPCR signaling, calcium signaling, and dopamine-DARPP32 cAMP signaling.
Activation of Enzymes Involved in Synaptic Plasticity
The ketogenic diet was found to significantly activate enzymes involved in synaptic plasticity, such as phospho-ERK and its downstream transcription factor CREB, in the hippocampus of both male and female APP/PS1 mice. This suggests that the ketogenic diet and BHB increase p-ERK activation, supporting early-phase LTP, and p-CREB activation, supporting late-phase LTP.
Effects on Amyloid Burden and Gliosis
Studies have investigated the impact of ketogenic diets on amyloid burden and gliosis, two key features of AD. While the ketogenic diet did not appear to reduce Aβ amyloid burden, it significantly reduced markers of microgliosis, suggesting that it may rescue LTP by reducing microglial inflammation without affecting Aβ deposits.
Influence on BDNF Levels
Brain-derived neurotrophic factor (BDNF), a protein that supports LTP, was found to be influenced by the ketogenic diet. While upstream LTP supporting factors p-ERK and p-CREB were significantly activated by the ketogenic diet in the hippocampi of both sexes, downstream BDNF only significantly rose in females.
Read also: Keto Calorie Counting: A Detailed Guide
Exploring the Lipidome and its Modulation by a Modified Ketogenic Diet
Lipids, essential components of cellular structure and function, play a crucial role in the brain. Altered lipid metabolism has been observed in AD, making it an important therapeutic target. A study using a targeted lipidomics platform examined the effect of a modified mediterranean ketogenic diet (MMKD) on the plasma lipidome in patients at risk for AD with and without cognitive impairment.
Key Findings from the Lipidomics Study
The study reported substantial changes to the plasma lipidome with the modified ketogenic diet, with these changes inversely related to a previously established signature of the AD lipidome. This suggests that the MMKD may have the potential to modify the lipid profile in a way that could be beneficial for individuals at risk of AD.
Practical Considerations and Future Directions
Implementing Ketogenic Diets in Real-World Settings
The feasibility and practicality of implementing ketogenic diets in real-world settings are important considerations. Studies have shown varying rates of retention among different ketogenic diets, with some diets, such as the modified Atkins diet, exhibiting higher dropout rates compared to others. Gastrointestinal issues caused by ingesting medium-chain triglycerides (MCTs) have also been identified as a common reason for dropout in studies using ketogenic diets with MCTs.
The Need for Further Research
While the existing research suggests that ketogenic diets may offer potential benefits for individuals with AD and those at risk of developing the disease, further research is needed to fully understand the mechanisms of action and optimize the implementation of these diets. Longitudinal studies involving large populations are recommended to determine the long-term effects of ketogenic diets on cognitive function and the prevention of AD.
Read also: Magnesium Supplements for Keto